Literature DB >> 26383613

The Efficacy of Medical Expulsive Therapy (MET) in Improving Stone-free Rate and Stone Expulsion Time, After Extracorporeal Shock Wave Lithotripsy (SWL) for Upper Urinary Stones: A Systematic Review and Meta-analysis.

Andreas Skolarikos1, Nikolaos Grivas2, Panagiotis Kallidonis3, Panagiotis Mourmouris1, Thomas Rountos4, Alexandros Fiamegos1, Sotirios Stavrou5, Chris Venetis6.   

Abstract

In this meta-analysis, we included randomized studies on medical expulsive therapy implemented following shock wave lithotripsy for renal and ureteral stones. Pooled results demonstrated the efficacy of α-blockers, nifedipine, Rowatinex, and Uriston in increasing stone clearance. In addition, the time to stone elimination, the intensity of pain, the formation of steinstrasse, and the need for auxiliary procedures were reduced mainly with α-blockers. Expulsion rate was not correlated with the type of α-blocker, the diameter, and the location of stone. Our results show that medical expulsive therapy for residual fragments after shock wave lithotripsy should be implemented in clinical practice.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26383613     DOI: 10.1016/j.urology.2015.09.004

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

Review 1.  Medical Expulsive Therapy: Worthwhile or Wishful Thinking.

Authors:  Tad Kroczak; Kenneth T Pace; Jason Y Lee
Journal:  Curr Urol Rep       Date:  2017-04       Impact factor: 3.092

Review 2.  Medical expulsive therapy for ureteral stones: where do we go from here?

Authors:  Bhaskar K Somani; Omar Aboumarzouk; Olivier Traxer; Joyce Baard; Guido Kamphuis; Jean de la Rosette
Journal:  Nat Rev Urol       Date:  2016-08-02       Impact factor: 14.432

Review 3.  How to maximize the efficacy of shockwave lithotripsy.

Authors:  Neophytos Petrides; Safiyah Ismail; Faqar Anjum; Seshadri Sriprasad
Journal:  Turk J Urol       Date:  2020-10-30

4.  Canadian Urological Association guideline: Management of ureteral calculi - Abridged version.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

5.  Canadian Urological Association guideline: Management of ureteral calculi - Full-text.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

6.  Outcomes of extracorporeal shock wave lithotripsy for ureteral stones according to ESWL intensity.

Authors:  Ji Hyung Yoon; Sejun Park; Seong Cheol Kim; Sungchan Park; Kyung Hyun Moon; Sang Hyeon Cheon; Taekmin Kwon
Journal:  Transl Androl Urol       Date:  2021-04

7.  Can intervals in extracorporeal shock wave lithotripsy sessions affect success in the treatment of upper ureteral stones?

Authors:  Turgay Turan; Ozgur Efioglu; Yavuz Onur Danacioglu; Furkan Sendogan; Meftun Culpan; Bilal Gunaydin; Ramazan Gokhan Atis; Turhan Caskurlu; Asif Yildirim
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-05-21       Impact factor: 1.195

Review 8.  Adjunctive medical expulsive therapy with tamsulosin for repeated extracorporeal shock wave lithotripsy: a systematic review and meta-analysis.

Authors:  Wei Ouyang; Guoliang Sun; Gongwei Long; Man Liu; Hua Xu; Zhiqiang Chen; Zhangqun Ye; Heng Li; Yucong Zhang
Journal:  Int Braz J Urol       Date:  2021 Jan-Feb       Impact factor: 1.541

9.  Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.

Authors:  Makinna C Oestreich; Robin Wm Vernooij; Niranjan J Sathianathen; Eu Chang Hwang; Gretchen M Kuntz; Alex Koziarz; Charles D Scales; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2020-11-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.